Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Gabapentinoide

USA. FDA, DEA Pushed to Make Gabapentin a Controlled Substance to Stop 'Widespread Misuse'

USA. FDA, DEA Pushed to Make Gabapentin a Controlled Substance to Stop 'Widespread Misuse'

In a bid to stop abuse and diversion of the anticonvulsant gabapentin, a watchdog group is petitioning federal regulators to make the drug a controlled substance. (Medscape, USA, 07.03.2022)

https://www.medscape.com/viewarticle/969829